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Ca2+ is a highly versatile intracellular signal that operates to
regulate a vast repertoire of cellular processes [1]. The ﬁrst evidence
that mitochondria can uptake Ca2+ dates back to the 1960s, when
pioneering studies demonstrated that energized mitochondria can
rapidly and efﬁciently accumulate Ca2+ [2,3]. Remarkably, these studies
preceded the chemiosmotic theory of Ca2+ accumulation [4].
In the following years, the basic properties of mitochondrial Ca2+
transport were clariﬁed: the rapid accumulation of Ca2+ into the mito-
chondrial matrix through the ion-impermeable inner mitochondrial
membrane (IMM) occurs via an electrogenic pathway, that relies on
the driving force of a steep electrochemical gradient attracting the
divalent ion. At the same time, two main efﬂux pathways (i.e. the
Na+/Ca2+ (mNCX) and H+/Ca2+ (mHCX) exchangers) are active,
ensuring that Ca2+ accumulation does not proceed until electrochemical
equilibrium is achieved [5].
However, when the mitochondrial Ca2+ uptake system was
functionally characterized, its afﬁnity was found to be too low to accu-
mulate the cation, not only in resting conditions but also during thedrial Channels edited by Pierre
edical Sciences, University of
ammucari),
pd.it (R. Rizzuto).
. This is an open access article undertransient cytosolic Ca2+ concentration ([Ca2+]cyt) increases generated
by cell stimulation. Thus, the plasma membrane and the endoplasmic
reticulum became the major players in the Ca2+ signaling scene while
mitochondria were neglected [1]. The scenario completely changed
with the development of genetically encoded Ca2+ probes speciﬁcally
targeted to the mitochondrial matrix, allowing direct measurement of
mitochondrial Ca2+ uptake in living cells [6]. It was shown that a large
[Ca2+]mt peak occurs dynamically in parallel to agonist-induced
[Ca2+]cyt increases. The speed and the amplitude of Ca2+ accumulation
into mitochondria greatly exceed the values that were previously pre-
dicted on the basis of MCU properties in isolated mitochondria. In addi-
tion, upon agonist stimulation, [Ca2+]mt reaches much higher values
than those in the cytosol [6]. The discrepancy between this prompt re-
sponse and the low afﬁnity of the Ca2+ transporter was reconciled by
the demonstration that mitochondria form close contacts with the
source of Ca2+ accumulation, i.e. the endoplasmic reticulum. Hence,
they are exposed to microdomains of high [Ca2+] that substantially
exceed the values in the bulk cytosol [7,8,9].
Given these groundbreaking discoveries, the study of mitochondrial
Ca2+ signaling became the primary goal of several laboratories. Indeed,
it was demonstrated that mitochondrial Ca2+ activates three matrix
dehydrogenases of the Krebs cycle, with consequent stimulation of ox-
idative phosphorylation and ATP synthesis [10], and that mitochondrial
Ca2+ overload is associated with cell death [11].
However, for many years the study of the physiological roles of
mitochondrial Ca2+ uptake has been severely limited by the lack of
the molecular identity of the Mitochondrial Calcium Uniporter (MCU),the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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step forward was the direct measurement of the MCU current (IMCU)
by patch clamping of the inner mitochondrial membrane [12]. Finally,
in 2011 our laboratory and that of V. Mootha simultaneously identiﬁed
CCDC109A as the pore-forming subunit of the Mitochondrial Calcium
Uniporter [13,14].
From that moment, the Ca2+ signaling ﬁeld witnessed an explosion
of discoveries aimed to clarify both the composition and functionality of
the MCU complex and the pathophysiological role of mitochondrial
Ca2+ uptake. In particular rapid progress was attained in characterizing
the role of MCU in cardiac and skeletal muscle.
In this contribution, we summarize the main ﬁndings on the molec-
ular structure and regulation of the Mitochondrial Calcium Uniporter
complex and its role in pathophysiology, with particular attention to
striated muscle tissues.2. Molecular components of the Mitochondrial Calcium
Uniporter complex
The uniporter complex, the highly selective channel responsible for
mitochondrial Ca2+ uptake, consists of both pore-forming and regulato-
ry subunits (Fig. 1 and [15]). MCUwas the ﬁrst structural component of
the pore to be identiﬁed in 2011 [13,14]. The MCU gene is well con-
served in all eukaryotes, except for yeast, encoding a 40 kDa protein
composed of two coiled-coil domains and two transmembrane domains
separated by a short hydrophilic loop enriched in acidic residues (the
“DIME” loop). MCU was shown to be sufﬁcient per se to mediate Ca2+
transport. Indeed, reconstitution ofMCUprotein in a planar lipid bilayer
gave rise to Ca2+ currentswith themain electrophysiological properties
previously recorded for theMitochondrial CalciumUniporter [12,13]. In
agreement with known uniporter properties, this current was inhibited
by ruthenium red and Gd3+ [13]. A critical amino acid residue responsi-
ble for this inhibition was identiﬁed in the loop region [14]. In addition,
isolated mitochondria from different tissues of the MCU knockout
mouse show no mitochondrial Ca2+ uptake [16], and silencing of MCU
inhibitsmitochondrial Ca2+ uptake inmany cell types and physiological
conditions [14,17–20].
MCU exists in a large protein complex (~480 kDa) [14], suggesting
that many other proteins contribute to the channel formation. Two
proteins were indeed shown to be part of the pore-forming subunit,
MCUb [21] and EMRE [22].Fig. 1.MCU comprises pore-formMCUb is anMCU related gene located onMusmusculus chromosome
3 (chromosome 4 for theHomo sapiens ortholog). The gene is present in
vertebrates but absent in other organisms in which MCU is present
(e.g., plants, kinetoplastids, Nematoda, and Arthropoda). The encoded
protein (330 amino acids long) is highly conserved among all species
and shares a 50% similarity with the MCU. It has two predicted trans-
membrane domains similar in sequence to the MCU although critical
amino-acid substitutions in the pore region prevent MCUb from
forming a Ca2+-permeable channel, thus acting as a dominant-
negative subunit [21]. Interestingly, MCUb/MCU ratio varies greatly
between tissues, suggesting that it might contribute to the spatio-
temporal control of mitochondrial Ca2+ uptake. Strikingly, this
correlateswith Ca2+ currentmeasurements by patch-clamp of different
tissues [23]. Indeed, tissues characterized by low mitochondrial Ca2+
transients, such as the heart, show a higherMCUb/MCU ratio, compared
to tissues such as skeletal muscle.
Another protein associated with the pore-forming subunit is the
recently identiﬁed EMRE (“essential MCU regulator”, previously
known as C22orf32), although whether or not EMRE is required to
form a functional Ca2+ channel is still debated. EMRE was identiﬁed
by SILAC-based quantitative mass spectrometry of afﬁnity-puriﬁed
MCU complex [22]. EMRE is a 10 kDa, metazoan speciﬁc protein with
a single transmembrane domain that spans the IMM and a highly
conserved C-terminus rich in aspartate residues. EMRE silencing
completely abrogates MCU activity in cells, even though MCU expres-
sion and oligomerization are preserved [22]. However, in a planar
lipid bilayer, MCU alone is sufﬁcient to give rise to Ca2+ currents, as
discussed above [13]. It was proposed that EMRE is required for the
interaction of MCU with MICU1 and MICU2, fundamental regulators of
the channel (see below), since EMRE silencing prevents MICU1 and
MICU2 to coimmunoprecipitate with MCU [22]. However, this data is
in contrast with bilayer experiments that showed that MICU1 is
sufﬁcient to induce MCU channel activity [24]. It is important to note
that MCU and MICU1 are conserved in plants, fungi and protozoa
whereas EMRE is not present. Consistently, in yeast and in mammalian
cells, Dictyostelium discoideumMCU homolog conducts Ca2+ in the ab-
sence of an EMRE homolog while, in these systems, human MCU re-
quires the presence of EMRE to act as a functional channel [25].
Recently, newdiscoveriesweremade, uncovering a previously unrecog-
nized role for matrix [Ca2+] in the regulation of MCU through EMRE
[26]. According to Vais et al. EMRE acts as Ca2+ sensor on both sides
of the IMM, with a mechanism that requires MICU1 and MICU2. Thus,ing and regulatory proteins.
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dria both from Ca2+ depletion and from Ca2+ overload [26].
One of the key features of mitochondrial Ca2+ uptake is the sigmoi-
dal response to extra-mitochondrial Ca2+ concentrations. In resting
conditions, mitochondrial Ca2+ uptake is inhibited despite the huge
driving force for matrix cation accumulation. This mechanism prevents
vicious cycling of cation accumulation, conspicuous energy drain,
morphological alterations and release of apoptotic cofactors [1]. On
the other hand, mitochondrial Ca2+ rapidly rises when the [Ca2+]
in the close proximity of mitochondria reaches a threshold value (N10
μM) [8,27,28]. Given the topology of the MCU, with only a small loop
facing the intermembrane space and the N- and C-termini residing in
the matrix [14,29], it seemed unlikely that MCU itself could be respon-
sible for these fundamental properties. Thus, the existence of a highly
sophisticated gatekeeping mechanisms was predicted, including both
negative modulators acting at low [Ca2+], and activators able to induce
Ca2+ currents during cell stimulation.
It is nowwidely accepted that the components of theMICU family of
mitochondrial EF-hand containing proteins are responsible for this vital
property ofmitochondrial Ca2+ uptake [30].MICU1 (formerly known as
EFHA3) was the ﬁrstmember of this family to be described, even before
themolecular identiﬁcation of MCU [31]. Amitochondrial compendium
of 1098 genes [32] was searched for membrane proteins evolutionarily
conserved in vertebrates and in kinetoplastids but absent in yeast, and
MICU1 was identiﬁed by an RNAi screen of the selected genes. MICU1
is a 54 kDa protein that possesses two EF-hand domains and a putative
transmembrane domain.Whether or not MICU1 is a membrane protein
is still being debated. It was originally shown to be associated with the
IMM [31] but its topology is still an open issue, since a number of studies
have reached different conclusions [22,33–35]. Recent proteomic exper-
iments strongly demonstrate that the components of the MICU family
reside in the intermembrane space [22,36,37]. As for the function,
MICU1 was initially shown to be necessary for mitochondrial Ca2+
uptake [31,38]. However, the group of M. Madesh demonstrated that
mitochondria lacking MICU1 are constitutively loaded with Ca2+ [33].
It was therefore hypothesized that MICU1 is fundamental to
prevent Ca2+ uptake at low [Ca2+]cyt, while playing a minor role at
higher [Ca2+]cyt. Complexity was added by the study performed by
G. Hajnóczky's laboratory [35]. The gatekeeper role of MICU1 at low
[Ca2+]cyt was conﬁrmed, but it was also shown that in the absence of
MICU1 the cooperativity ofmitochondrial Ca2+ uptake is lost, suggesting
that MICU1 plays a dual function depending on [Ca2+]cyt. Coherently,
studies in human patients, in which loss of function mutations in
MICU1 cause a disease phenotype characterized by proximal myopathy,
learning difﬁculties and a progressive extrapyramidal movement
disorder, showed increased mitochondrial Ca2+ load. This increase was
observedboth at basal cytosolic Ca2+ concentrations and after spontane-
ous, low-frequency, transient increases in cytoplasmic Ca2+ levels [39].
However, these studies preceded the identiﬁcation of MICU1
paralogs [40], MICU2 (formerly known as EFHA1) andMICU3 (formerly
known as EFHA2), also characterized by the presence of two highly
conserved EF-hand domains. MICU2 and MICU3 likely arise from gene
duplication in vertebrates and show highly different expression proﬁles
in mouse tissues. Indeed, MICU3 expression is restricted to the central
nervous system and, at lower levels, to skeletal muscle [40], while
MICU2 shares a similar tissue distribution and the intermembrane
space localization with MICU1 [36]. MICU2 forms an obligate heterodi-
mer with MICU1 through a disulﬁde bond that interacts with MCU in
the DIME loop, i.e. the short intervening region between the two
transmembrane domains (Fig. 1 and [24]). MICU2 inhibits the channel
activity of puriﬁed MCU in planar lipid bilayers and reduces channel
opening at resting [Ca2+] in intact HeLa cells, thus ensuring minimal
Ca2+ accumulation. Importantly, MICU2 protein stability depends
on the presence of MICU1 [24,40,41], suggesting that the loss of the
gatekeeping property of MCU in MICU1 silenced conditions [33,35] is
due to the concomitant reduction of MICU2 expression. In addition, as[Ca2+]cyt increases upon cell stimulation, Ca2+-dependent conforma-
tional changes of theMICU1-MICU2dimer releaseMICU2dependent in-
hibition (Fig. 1). At the same time MICU1 stimulates MCU activity,
acting as the cooperative activator of the channel (Fig. 1). Accordingly,
a MICU2 mutant unable to bind Ca2+ acts as gatekeeper also in condi-
tions of high [Ca2+]cyt while, in the same conditions, MICU1 mutant
loses the capability to cooperatively activate the channel [24].
As for MICU3, its speciﬁc function is still unknown. Moreover, its
restricted expression in the CNS and skeletal muscle [40] suggests a
tissue speciﬁc mitochondrial Ca2+ uptake mechanism that still needs
to be thoroughly investigated.
Another protein whose role is not yet deﬁnitive is theMitochondrial
Calcium Uniporter Regulator 1 (MCUR1, formerly known as coiled-coil
domain-containing 90A or CCDC90A) that was discovered thanks to
an RNAi screen of mitochondrial genes that regulate mitochondrial
Ca2+ uptake [42]. MCUR1 is a 40 kDa inner membrane protein that
possesses two transmembrane spanning helices. MCUR1 was shown
to be required for uniporter activity [42]. Indeed, its silencing abrogates
mitochondrial Ca2+ uptake while its overexpression enhances MCU
activity. This protein was shown to interact with MCU [42], although
mass spectrometry of MCU interactors failed to identify MCUR1 [22].
In yeast and human cells, suppression of MCUR1 causes a speciﬁc cyto-
chrome c oxidase (COX) assembly defect and decreased mitochondrial
membrane potential (Δψm), with consequent reduction in mito-
chondrial Ca2+ uptake [43]. This observation, together with the
evidence that yeast MCUR1 orthologous lacks uniporter activity, sug-
gests an indirect function of MCUR1 in regulating mitochondrial
Ca2+ uptake. However, measurements of MCU-mediated Ca2+ cur-
rents by patch clamp electrophysiology of mitoplasts showed that
MCUR1 knockdown diminishes MCU Ca2+ currents independently
of differences in Δψm [44]. Thus, further experiments are necessary
to clarify the role of MCUR1.
3. The physiological role of mitochondrial Ca2+ uptake in
non-muscle tissues
Before themolecular identiﬁcation of the uniporter complex compo-
nents, the established roles of mitochondrial Ca2+ signaling included
stimulation of ATP production, buffering of cytosolic Ca2+ transients
and regulation of cell death [1]. In parallel with the elucidation of the
molecular identity and functions of the components of the MCU com-
plex, a number of studies have been performed aimed to elucidate the
biological functions of Ca2+ transport. In this part of the review we
will summarize the principal ﬁndings on the role of mitochondrial
Ca2+ homeostasis in non-muscle cells.
The ﬁrst studies, in chronological terms, examined the role of MCU in
glucose-induced ATP production in pancreatic β-cells [15,35]. In these
cells, the glucose-dependent stimulation of oxidative metabolism
elevates cytosolic [ATP], responsible for the closure of ATP-sensitive K+
(KATP) channels in the plasmamembrane, causing cell membrane depo-
larization and Ca2+ inﬂux via voltage-gated Ca2+ channels. These events
trigger the ﬁrst phase of insulin secretion. In addition to this triggering
pathway, glucose also activates an essential metabolic amplifying path-
way that increases the action of Ca2+ on exocytosis (for review, see [47]).
Immediately before the discovery of the MCU, it was demonstrated
that mitochondrial [Ca2+] increases, caused by Ca2+ entry through
the plasma membrane, are necessary for the ampliﬁcation of sustained
glucose-dependent insulin secretion [48]. In this model, glucose is sufﬁ-
cient to induce ATP synthesis in the ﬁrst phase of insulin secretion but
mitochondrial Ca2+-dependent ATP production is required for the
more pronounced sustained phase. The discovery of MCU and MICU1
allowed a ﬁner manipulation of mitochondrial Ca2+ entry in β-cells.
Silencing of MCU [19,45,49] and MICU1 [46] conﬁrmed that Ca2+
entry through the plasma membrane triggers mitochondrial Ca2+
uptake via the MCU complex that further accelerates oxidative
phosphorylation and hence ATP production, contributing to sustained
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mide, a potassium channel blocker used in the management of type II
diabetes, is dependent onMCU activity [45]. Since defects in the glucose
sensitivity and function of β-cells are crucial aspects of type 2 diabetes
(T2D) and alterations of β-cell Ca2+ homeostasis are observed in T2D
[50], it is plausible that pharmacological modulation of the MCU com-
plex could represent a winning strategy to regulate insulin secretion
in vivo andmight provide a new approach to improve glucose tolerance.
Due to the important implications in health and disease, the role of
mitochondrial Ca2+ signaling in controlling cell death and cancer
progression has been extensively investigated. Inmany cell types, mito-
chondrial Ca2+ overload plays a permissive role in cell death by trigger-
ing the opening of the mPTP and the release of caspase cofactors [1]. As
expected, mitochondria from total MCU knockout mice show no mPTP
opening upon addition of extramitochondrial Ca2+. However, MEF
cells derived from these animals show no difference in the kinetics or
magnitude of cell death upon different stimuli compared to MEF cells
derived from wild type mice [16].
Increased levels of mitochondrial Ca2+ uptake, either by MCU over-
expression [13] orMICU1 silencing [33], sensitize HeLa cells to apoptotic
stimuli. Consistent with the data correlating MCU expression and cell
death, increased levels of miR-25 that speciﬁcally reduce MCU protein
levels confer resistance of cancer cells to apoptotic stimuli, and this
effect is reversed by anti-miR-25 overexpression [51].
However, MCU expression is induced in estrogen receptor (ER)-
negative breast cancers that are associated with poor prognosis
[52]. In addition, MCU silencing does not have any effect on cell
apoptosis of the highly aggressive triple negative breast carcinoma
cell line MDA-MB-231 [52,53], suggesting that these cells primarily
utilize MCU-independent mechanisms for survival. In this cell line,
only caspase-independent cell death was potentiated byMCU silencing
[52]. MCU plays a critical role in MDA-MB-231 migration with a mech-
anism that has been ascribed to be dependent on store-operated Ca2+
entry [54]. We have now shown that MCU expression correlates with
breast cancer progression, and that MCU depletion inhibits in vivo
tumor growth andmetastasis formation,with amechanism that implies
reduced ROS formation and HIF-1α expression, while the role of store-
operated Ca2+ entry is not totally unambiguous [55].
The contribution of mitochondrial Ca2+ overload to cell death has
been systematically investigated in cortical neurons. MCU overexpres-
sion exacerbates NMDAR-dependent increases in mitochondrial Ca2+,
loss of mitochondrial membrane potential and excitotoxic cell death
[20]. Furthermore, MCU expression seems to be precisely suppressed
by synaptic activity that promotes neuroprotection against excitotoxic
insults [56], via a mechanism involving nuclear Ca2+ and CaM kinase-
mediated induction of the transcription factor Npas4. A conﬁrmation
of the importance of mitochondrial Ca2+ uptake in brain comes from
the discovery of a loss-of-function mutation of MICU1 in individuals
with a neuromuscular disease characterized by learning difﬁculties
and an extrapyramidal disorder [39], although surprisingly no abnor-
malities have been reported in the MCU knockout mice [16]. Among
the several aspects that still need to be addressed, the deﬁnition of the
role of MICU3, whose expression is restricted to the nervous system,
will be of great interest.
4. Role of MCU in cardiac physiopathology
Cardiacmitochondria are themajor source of ATP, required for heart
function, and inhibition of mitochondrial ATP synthesis leads to loss
of contractile capacity and cell death [57]. While the importance of
mitochondria metabolism in the heart is undisputed, the role of mito-
chondrial Ca2+ uptake in shaping cytosolic [Ca2+] and its consequences
on heart pathophysiology remains controversial (Fig. 2).
Direct patch-clampmeasurements of IMCU in mitoplasts leads to the
unexpected ﬁnding thatIMCU in mouse heart is substantially smaller
than other mouse tissues. In particular heart IMCU is 30 times smallerthan skeletal muscle IMCU [23]. Nonetheless skeletal muscle and heart
mitochondrial Ca2+ currents share the same biophysical properties,
indicating that the difference in current density is not due to differences
in the proteins responsible for channel activity. These ﬁndings have
multiple possible explanations: i) in the heart, mitochondria occupy
up to 37% of the cell volume, thus it is plausible that mitochondrial
Ca2+ uptake is kept low in order to not abolish the cytosolic Ca2+
transients necessary for heart beating, ii) frequent elevation of
cytosolic Ca2+, if efﬁciently translated into mitochondrial Ca2+ uptake,
could lead to futile cycling of Ca2+ across the IMM, mitochondrial Ca2+
overload and damage.
Theﬁrst study on neonatal cardiomyocytes after themolecular iden-
tiﬁcation of MCUwas aimed at understanding whether and to what ex-
tent beat-to-beat mitochondrial Ca2+ oscillations depend on hot spots
generated on their surface, and whether mitochondrial Ca2+ uptake
shapes cytosolic Ca2+ transients [58]. Indeed, whether or not mito-
chondrial Ca2+ uptake buffers systolic Ca2+ peaks remained an un-
resolved question. In addition, the dynamics of mitochondrial Ca2+
uptake during contraction were unclear. T. Pozzan laboratory inves-
tigated the existence and amplitude of high [Ca2+] microdomains at
the SR/mitochondria contacts and analyzed the role of MCU in mito-
chondrial Ca2+ uptake and on buffering of cytosolic Ca2+ transients.
Taking advantage of a GFP-based Ca2+ indicator targeted at the
OMM, the authors demonstrated that 20–30 μM Ca2+ hot spots are
formed during systole. In addition, modulation of MCU levels by
overexpression or silencing, reduced and increased the amplitude
of beat-to-beat cytoplasmic Ca2+ oscillation respectively.
Analysis of theMCU knockout mouse brought surprising results that
are still being debated [16,59] (Fig. 2). As expected MCU knockout
cardiac mitochondria had impaired Ca2+ uptake and Ca2+-dependent
oxygen consumption. Yet, basal ATP levels were unaltered, suggesting
that MCU depletion does not affect basal mitochondrial metabolism
[59]. Both in 12 and in 20 month-old mice, basal heart parameters
were indistinguishable fromwild type animals. In addition, left ventric-
ular cardiac output at baseline and following isoproterenol treatment
were similar in MCU knockout versus wild type mice [59], even though
the rise in mitochondrial [Ca2+] induced by isoproterenol in wild type
cardiacmyocytes did not occur inMCU depleted cells [16]. Unexpected-
ly, while cyclosporine A (CsA), which inhibits Ca2+-dependent cell
death mediated by mPTP opening, protected wild type hearts from
ischemia–reperfusion injury, infarct area in MCU knockout hearts was
similar to control hearts, and CsA did not exert any protection. This sug-
gests that Ca2+-independent death pathways take place in the absence
of MCU [16]. Also, upon transverse aortic constriction (TAC) overall
survival as well as histologic parameters like hypertrophy and ﬁbrosis
were similar among the two genotypes [59].
The mild phenotype observed in MCU knockout hearts could be
partially explained by the observation that resting free [Ca2+] in knock-
out mitochondria is only partially reduced [16]. These data suggested
the existence of alternative mechanisms for Ca2+ accumulation,
althoughMCU knockoutmitochondria and intact cells were not capable
of any energy-dependent Ca2+ uptake [16]. Of note, MCU knockout
mice are viable only on a mixed genetic background, and not even
at Mendelian ratio, while deletion of MCU on the inbred C57BL/6
background is embrionically lethal [60]. Thus, in themixed background,
compensatory mechanisms that justify animal viability could in
principle take place.
Further studies were conducted in a transgenic mouse model
in which MCU activity was inhibited by the overexpression of a
dominant-negative form of MCU under the control of αMHC promoter
(DN-MCU) [61,62] (Fig. 2). DN-MCU mitochondria were unable of
taking up Ca2+, but no differences were observed in terms of cardiac
and mitochondria morphology and baseline heart function. Despite
the lack of differences in basal heart rate and weight, O2 consumption
rates (OCR) were increased in DN-MCU isolated perfused hearts, but
not in isolated mitochondria or permeabilized ﬁbers. Additionally,
Fig. 2. Cardiac phenotypes of MCU mouse models.
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cytosolic Ca2+, in DN-MCU hearts increases in cytoplasmic [Ca2+]
were observed, that were partially reversed by ATP dialysis. These
data indicate that inhibition of MCU activity results in: i) reduced
heart performance and ii) enhanced energetic demand related to
extramitochondrial Ca2+ signaling. Nonetheless, in agreement with
ﬁndings on MCU knockout mouse, inhibition of MCU activity by
DN-MCU was inefﬁcient in protecting hearts from cell-death induced
by ischemia–reperfusion injury [62].
Further insights demonstrated that the main defect of DN-MCU
hearts is the impairment of the “ﬁght or ﬂight” response, i.e. the
physiological heart rate acceleration consequent to catecholamine
stimulation [61]. Speciﬁcally, prolonged P-waves, PQ and PR intervals
were measured within DN-MCU mice being compared to wild type
animals, while QRS and QT interval durations were similar. These data
indicate a selective reduction in atrial and atrioventricular conduction
velocity, while conduction velocities in the distal conduction system
or in the ventricular myocardium were unaffected. MCU was shown to
be essential for increased mitochondrial Ca2+ uptake in sinoatrial
nodal (SAN) pacemaker cells, with consequent stimulation of oxidative
phosphorylation. Increased ATP synthesis thus sustains SERCA activity
and prompts SR reﬁlling during heart rate acceleration [61].
Both MCU knockout and DN-MCU mouse models are characterized
by constitutive modulation of MCU activity which begins during devel-
opment. Adaptations to embryonic long-term loss of mitochondrial
Ca2+ uptake cannot be excluded. Thus, a mouse model in which MCU
is speciﬁcally deleted in adult cardiomyocytes was developed (Fig. 2
and [63,64]). Acute cardiac-speciﬁc deletion of MCU did not only trigger
growth defects, as expected, but also did not cause lactic acidosis and
phosphorylation of PDH. Analyses of heart structure and function
show both similarities and differences with previous models.
Ca2+-induced mitochondrial Ca2+ uptake, but not basal mitochondrial
Ca2+, was drastically reduced in MCU-depleted cardiac mitochondria.
Still, heart morphology and ultrastructure, as well as basal cardiac func-
tions were unaltered. When subjected to chronic damage by transverse
aortic constriction (TAC), no differences were observed in heart weight,
cardiomyocyte area and fractional shortening. However, in contrast towhat was previously reported for constitutive MCU inhibition mouse
models [16,62], deletion of MCU in adult cardiomyocytes leads to
protection from cell death induced by acute damage such as
ischemia–reperfusion injury. As already observed in MCU knockout
mice, acute MCU deletion caused desensitization of Ca2+-induced
mPTP opening. OCR and ATP synthesis were similar between wild
type and acutely deleted MCU heart mitochondria in basal conditions,
in line with basal mitochondrial Ca2+ measurements. However, MCU
was required for short-term OCR increase by Ca2+ or β-adrenergic
receptor agonist stimulation. Of note, OCR in MCU knockout adult
cardiomyocytes eventually reached the values of wild type cells,
suggesting that MCU is critical for acute mitochondrial Ca2+ uptake in
conditions of increased heart work and that alternative mechanisms
are responsible for slow Ca2+ accumulation. Similarly, performance
during a treadmill protocol of strenuous work was decreased in adult
cardiomyocyte-speciﬁc MCU knockout mice. However, if mice were
allowed to warm-up for enough time, no differences were observed
among wild type and knockout animals.
Mitochondrial Ca2+ uptake is regulated by various mechanisms. As
for the heart, Ca2+/calmodulin-dependent protein kinase II (CaMKII)
has been proposed to induce mPTP opening-dependent myocardial
death by increasing IMCU [18]. Transgenic mice with myocardial expres-
sion of CaMKIIN, a CaMKII inhibitor, targeted to mitochondria, were
protected against ischemia–reperfusion injury and showed reduced
mitochondrial Ca2+ uptake and IMCU. CaMKII catalytic activity was
essential for increased IMCU and two CaMKII target sites, required for
CaMKII-induced IMCU, were identiﬁed in the MCU sequence. However,
IMCU recordings and evidence for the CaMKII-dependent MCU regula-
tion, reported in the study by Joiner et al. [18], have been questioned.
Fieni et al. [65] highlighted that the IMCU recorded in the Joiner at al.
study was two orders of magnitude greater than the one previously
measured, and characterized by high ﬂuctuations incompatible with
the low single-channel conductance of MCU. Further studies are
required to clarify this issue.
Other post-transcriptional regulations of MCU activity have been
described in cardiac cells [66]. In particular, α1-adrenoceptor (α1-AR)
activation by the α1-AR agonist phenylephrine triggered translocation
2462 C. Mammucari et al. / Biochimica et Biophysica Acta 1863 (2016) 2457–2464of activated proline-rich tyrosine kinase 2 (Pyk2) from the cytosol to the
mitochondrial matrix. Once in the matrix, Pyk2 phosphorylates MCU
and accelerates its tetrameric oligomerization, eventually triggering
mitochondrial Ca2+ uptake increase. In cardiac cells, while
MCU overexpression caused increased mitochondrial superoxide
upon phenylephrine treatment, the opposite effect was observed
by Pyk2 inhibition. In addition, the α1-AR-Pyk2 axis was shown to
initiate cell death in adult cardiomyocytes.
Great interest is now placed on the role of miRNA in cardiac patho-
physiology. As noted above, MCU has been identiﬁed as a target of
miR-25 andMCUprotein levels inversely correlate withmiR-25 expres-
sion [51,67]. Expression of miR-25 in cardiomyocytes is increased upon
oxidative stress, and overexpression of miR-25 decreasesmitochondrial
Ca2+ uptake and reduces apoptotic cell death eventually protecting
cardiomyocytes from oxidative damage, suggesting that the protective
role of miR-25 in cardiac pathology is mediated by MCU-dependent
mitochondrial Ca2+ signaling [67].
5. Mitochondrial Ca2+ signaling in skeletal muscle homeostasis
In contrast to heart tissue, only 5% of skeletal muscle cell volume is
occupied by mitochondria. Possibly because they are not exposed to
frequent Ca2+ elevations, skeletal muscle mitochondria display much
higher IMCU compared to the heart [23]. As mentioned above, MCU
knockout mice display a mild phenotype, although skeletal muscle is
the most affected tissue [16]. Stimulation of O2 consumption by Ca2+
is suppressed in MCU knockout muscle mitochondria, although
matrix Ca2+ levels are reduced only by about 75%. PDH phosphor-
ylation is increased in MCU knockout muscles, in agreement with
the Ca2+-dependent regulation of PDP1 phosphatase, consequently
PDH activity is decreased. In line with the role of mitochondrial Ca2+
uptake to stimulate ATP production required for muscle function,
MCU knockout mice show reduced maximal power output (Fig. 3).
To overcome the possible compensatory effects of the MCU knock-
out mouse during embryonic development, the role of MCU in skeletal
muscle homeostasis has been further investigated by overexpressing
or silencing MCU speciﬁcally in skeletal muscle a few days after birth
and in adulthood (Fig. 3). For this purpose, infection of skeletal muscle
with Adeno-associated viral vectors (AAVs) was used [68]. MCUFig. 3. In vivo skeletal moverexpression triggered skeletal muscle hypertrophy, while MCU si-
lencing causes muscle atrophy, both during post-natal development
and in adulthood. Most importantly, MCU overexpression protected
muscles from the loss of muscle mass during denervation, indicating a
potential therapeutic role of MCU modulation in muscle atrophy. A
purely metabolic effect was excluded as a possible mechanism since
PDH activity was unaffected by MCU overexpression, although as re-
ported for theMCU knockout, PDH activity was reduced in shMCUmus-
cles. In addition, the trophic effect was very similar between glycolytic
and mitochondria-rich oxidative muscles, in which mitochondrial me-
tabolism plays different roles. Nonetheless, mitochondria volume was
modulated byMCU, suggesting a role formitochondrial Ca2+ in the reg-
ulation of organelle biogenesis and morphology. As for the mechanism,
established hypertrophy pathways, like IGF1-Akt/PKB and PGC-1α4,
were responsible for the regulation of muscle size by MCU (Fig. 3). In
addition, RNAmicroarray analyses demonstrated that MCUmodulation
controls global gene expression, thus identifying a Ca2+-dependent
mitochondria-to-nucleus route that links mitochondrial function to
the control ofmusclemass [68,69] (Fig. 3). The idea that in skeletalmus-
cle mitochondrial Ca2+ uptake is fundamental for tissue homeostasis
was strongly supported by the discovery of human patients harboring
a loss-of-function MICU1 mutation and with a disease phenotype char-
acterized by proximal myopathy, learning difﬁculties and progressive
extrapyramidal movement disorder [39]. Strikingly, the increase in mi-
tochondrial Ca2+ uptakewas able to buffer cytoplasmic Ca2+ transients
despite normal mitochondrial membrane potential. In addition, mito-
chondrial network was severely fragmented. Altogether these ﬁndings
demonstrate that mitochondrial Ca2+ signaling in skeletal muscle is
fundamental in human pathophysiology.6. Conclusions
The study of the dynamic regulation of mitochondrial Ca2+ uptake
and its contribution to pathophysiology greatly advanced after the
discovery of the molecular identity of MICU1 [70], followed soon after
by MCU [13,14], and of the other interactors in the following years.
We predict that many open questions, some of which are summarized
hereafter, will be answered in the near future.uscle phenotypes.
2463C. Mammucari et al. / Biochimica et Biophysica Acta 1863 (2016) 2457–2464MCU activity is regulated by conformational changes in the MCU
complex and at least partially controlled by Ca2+ itself. MICU1 and
MICU2 are the two major players in this modulation, and different
studies are aimed to understand their role. However, some issues
concerning the relative contribution of one to the other's function,
as well as their role in the modulation of mitochondrial Ca2+ uptake
in basal versus stimulated [Ca2+]cyt, are still under debate. In addition,
the role MCUR1 in modulating channel activity is still uncertain, and
the role of MICU3 in the regulation of mitochondrial Ca2+ uptake in
the nervous system is also still largely unknown.
The expression levels of the different MCU complex components
have been analyzed in various tissues and cell lines. In some cases, the
relative expression of MCU and of its interactors is in line with the
predicted mitochondrial Ca2+ uptake behavior (e.g. skeletal muscle
expresses high levels of MCU, compared to other tissues). However,
especially in cell lines, this paradigm is not always conﬁrmed, indicating
that other regulatory systems contribute to MCU activity. In addition,
the study of gene regulation of MCU complex components is still in its
early stages.
Some work has been done on the post-transcriptional regulation
of MCU complex, which certainly plays an important role. However, in
some cases contradictory results have been reported, indicating that
further studies are required.
The surprisingly mild phenotype of the MCU knockout mouse has
been discussed in many published reviews and comments. Since its
description, tissue-speciﬁc and inducible knockout animals have been
developed, in order to i) discern the contribution of MCU in single
organs and ii) overcome possible compensatory mechanisms that may
occur during development. This approach brought clariﬁcation of the
role of MCU in the heart, where MCU has been shown to be involved
in the ﬁght or ﬂight response. The same should be done for other
organs and tissues, including skeletal muscle, the nervous system and
pancreatic β-cells.
In parallel to deﬁning the contribution of MCU activity to patholo-
gies, the discovery of drugs thatmodulateMCUactivitywill be extreme-
ly important for the future development of putative MCU-targeting
therapies.
The uniporter is formed by MCU protein, by the dominant negative
subunit (MCUb) and EMRE. In low [Ca2+]cyt the regulatory subunit
MICU2 keeps the channel closed (left). In conditions of [Ca2+]cyt
elevation, MICU2 is inhibited, while MICU1 is activated and acts as a
cooperative activator of MCU (right).
Comparison of heart phenotypes among the differentmousemodels
in which MCU activity is inhibited.
Deletion of the MCU gene causes reduction in maximal power out-
put. Post-natal and skeletal muscle-speciﬁc knockdown ofMCU triggers
atrophy, while MCU overexpression causes hypertrophy. Established
muscle trophism pathways are modulated by MCU.Transparency document
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